References
- KrollRANeuweltEAOutwitting the blood-brain barrier for therapeutic purposes: Osmotic opening and other meansNeurosurgery19984210831099 discussion 1099–11009588554
- McDannoldNVykhodtsevaNHynynenKEffects of acoustic parameters and ultrasound contrast agent dose on focused-ultrasound induced blood-brain barrier disruptionUltrasound Med Biol20083493093718294757
- Cordon-CardoCO’BrienJPCasalsDMultidrug-resistance gene (p-glycoprotein) is expressed by endothelial cells at blood-brain barrier sitesProc Natl Acad Sci U S A1989866956982563168
- MotzerRJMazumdarMGulatiSCPhase ii trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsJ Natl Cancer Inst199385182818357693955
- MotzerRJMazumdarMBajorinDFBoslGJLynPVlamisVHigh-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumorsJ Clin Oncol199715254625529215823
- YangFYWangHELinGLMicro-spect/ct-based pharmacokinetic analysis of 99mtc-diethylenetriaminepentaacetic acid in rats with blood-brain barrier disruption induced by focused ultrasoundJ Nucl Med20115247848421321259
- YangFYHorngSCLinYSKaoYHAssociation between contrast-enhanced mr images and blood-brain barrier disruption following transcranial focused ultrasoundJ Magn Reson Imaging20103259359920815056
- YangFYLinYSKangKHChaoTKReversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasationJ Control Release201115011111621070825
- YangFYLiuSHHoFMChangCHEffect of ultrasound contrast agent dose on the duration of focused-ultrasound-induced blood-brain barrier disruptionJ Acoust Soc Am20091263344334920000948
- BekeredjianRKrollRFeinEUltrasound targeted microbubble destruction increases capillary permeability in hepatomasUltrasound Med Biol2007331592159817618040
- BekeredjianRChenSGrayburnPAShohetRVAugmentation of cardiac protein delivery using ultrasound targeted microbubble destructionUltrasound Med Biol20053168769115866418
- BrujanEAThe role of cavitation microjets in the therapeutic applications of ultrasoundUltrasound Med Biol20043038138715063520
- MillerDLQuddusJSonoporation of monolayer cells by diagnostic ultrasound activation of contrast-agent gas bodiesUltrasound Med Biol20002666166710856630
- YangFYTengMCLuMTreating glioblastoma multiforme with selective high-dose liposomal doxorubicin chemotherapy induced by repeated focused ultrasoundInt J Nanomedicine2012796597422393293
- YangFYWangHELinGLLinHHWongTTEvaluation of the increase in permeability of the blood-brain barrier during tumor progression after pulsed focused ultrasoundInt J Nanomedicine2012772373022359451
- YangFYWongTTTengMCFocused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiformeJ Control Release332012 [Epub ahead of print.]
- YangFFuWChenWYehWLinWQuantitative evaluation of the use of microbubbles with transcranial focused ultrasound on blood-brain-barrier disruptionUltrason Sonochem20081563664317910929
- YangFFuWYangRLiouHKangKLinWQuantitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruptionUltrasound Med Biol2007331421142717561334
- SharmaHSDeyPKInfluence of long-term immobilization stress on regional blood-brain barrier permeability, cerebral blood flow and 5-ht level in conscious normotensive young ratsJ Neurol Sci19867261762936871
- McDannoldNVykhodtsevaNHynynenKTargeted disruption of the blood-brain barrier with focused ultrasound: Association with cavitation activityPhys Med Biol20065179380716467579
- UngerECMcCreeryTPSweitzerRHCaldwellVEWuYAcoustically active lipospheres containing paclitaxel: A new therapeutic ultrasound contrast agentInvest Radiol1998338868929851823
- BednarskiMDLeeJWCallstromMRLiKCIn vivo target-specific delivery of macromolecular agents with mr-guided focused ultrasoundRadiology19972042632689205257